Angelica Fernandez Dizon, NP | |
1145 19th St Nw Ste 410, Washington, DC 20036-3716 | |
(202) 331-1740 | |
(202) 296-9784 |
Full Name | Angelica Fernandez Dizon |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 30 Years |
Location | 1145 19th St Nw Ste 410, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023522638 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | RN1004381 (District Of Columbia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Maryland Cardiology Associates Llc | 8527029743 | 14 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.
› Verified 9 days ago
Entity Name | Maryland Cardiology Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982752747 PECOS PAC ID: 8527029743 Enrollment ID: O20041021000418 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.
› Verified 9 days ago
Entity Name | Accessible Integrative Medicine, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861986572 PECOS PAC ID: 8527318880 Enrollment ID: O20180906002462 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.
› Verified 9 days ago
Entity Name | Legacy Spine And Pain, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447755178 PECOS PAC ID: 6709137284 Enrollment ID: O20180921002060 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Angelica Fernandez Dizon, NP 1145 19th St Nw Ste 410, Washington, DC 20036-3716 Ph: (202) 331-1740 | Angelica Fernandez Dizon, NP 1145 19th St Nw Ste 410, Washington, DC 20036-3716 Ph: (202) 331-1740 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.
A new study in mice shows how social support can help minimize some of the worst physical damages to the brain caused by a heart attack.
› Verified 9 days ago
Ms. Janet E Jumper, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, 4b42, Washington, DC 20010 Phone: 202-877-7462 | |
Arlyne E Heerlein, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Us Dept Ofstate, 2401 E St., Nw, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Seble Yirga, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-7265 Fax: 202-444-4208 | |
Daniel Richard Stairiker, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 202-537-4000 | |
Monica Elston, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw # 3phc, Washington, DC 20007 Phone: 202-444-8531 | |
Sarah Katkhouda, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1627 I St Nw Ste 800, Washington, DC 20006 Phone: 202-204-7092 | |
Ms. Desiree Rivas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 I St Ne, Washington, DC 20002 Phone: 703-867-2503 |